Dashboard
Manage Tickers

ZLABZai Lab Ltd

Nasdaq zailaboratory.com


$ 19.88 $ 0.21 (1.07 %)    

Friday, 06-Sep-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 19.85
$ 19.85 x 200
-- x --
-- - --
$ 13.48 - $ 31.22
596,608
na
34.9B
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

zai-lab-to-present-preliminary-data-from-phase-1-trial-of-zl-1218-for-the-treatment-of-advanced-solid-tumors-at-esmo-congress-2024
Zai Lab To Present Preliminary Data From P...
08/27/2024 12:41:18

Poster session will highlight potential of ZL-1218 to modulate tumor microenvironment and regulate anticancer immune response i...

cantor-fitzgerald-reiterates-overweight-on-zai-lab
Cantor Fitzgerald Reiterates Overweight on...
08/07/2024 18:03:30

Cantor Fitzgerald analyst Louise Chen reiterates Zai Lab (NASDAQ:ZLAB) with a Overweight.

zai-lab-shares-are-trading-higher-after-the-company-reported-better-than-expected-q2-sales-results-also-the-company-said-it-expects-substantial-topline-growth-and-path-to-achieve-profitability-by-the-end-of-2025
Zai Lab shares are trading higher after th...
08/07/2024 12:28:48

zai-lab-targets-substantial-topline-growth-and-achieve-profitability-by-the-end-of-2025
Zai Lab Targets Substantial Topline Growth...
08/06/2024 20:39:50

zai-lab-q2-2024-gaap-loss-per-ads-082-misses-070-estimate-sales-100504m-beat-93136m-estimate
Zai Lab Q2 2024 GAAP Loss Per ADS $(0.82) ...
08/06/2024 20:15:49

Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.82) per ADS which missed the analyst consensus estimate of $(0.70) by 17...

Core News & Articles
Zai Lab And argenx Get Approval For Efgart...
07/16/2024 05:13:51

First and only NMPA-approved subcutaneous (SC) injectable providing additional flexibility and optionality for gMG patients i...

zai-lab-announces-publication-from-chinas-gynecology-oncology-field-in-cell-study-highlights-niraparibs-effect-on-ovarian-cancer-microenvironment-stratified-by-hrd-and-its-perturbation-by-parp-inhibitor-data-suggest-combination-of-niraparib-and-investigational-ccr8-antibody-zl-1218-may-decrease-tumor-burden
Zai Lab Announces Publication From China's...
07/15/2024 18:57:11

Manuscript represents the first publication from China's gynecology oncology field to be published in CellPublication highl...

jp-morgan-maintains-overweight-on-zai-lab-lowers-price-target-to-38
JP Morgan Maintains Overweight on Zai Lab,...
07/12/2024 15:09:59

JP Morgan analyst Anupam Rama maintains Zai Lab (NASDAQ:ZLAB) with a Overweight and lowers the price target from $43 to $38.

cantor-fitzgerald-reiterates-overweight-on-zai-lab
Cantor Fitzgerald Reiterates Overweight on...
07/01/2024 13:12:48

Cantor Fitzgerald analyst Louise Chen reiterates Zai Lab (NASDAQ:ZLAB) with a Overweight.

cantor-fitzgerald-reiterates-overweight-on-zai-lab
Cantor Fitzgerald Reiterates Overweight on...
06/25/2024 14:58:08

Cantor Fitzgerald analyst Louise Chen reiterates Zai Lab (NASDAQ:ZLAB) with a Overweight.

why-core--main-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Core & Main Shares Are Trading Lower B...
06/04/2024 16:54:09

saia-annexon-core-scientific-and-other-big-stocks-moving-higher-on-tuesday
Saia, Annexon, Core Scientific And Other B...
06/04/2024 14:08:59

zai-lab-has-dosed-the-first-patient-in-the-phase-2-trial-of-zl-1102-for-chronic-plaque-psoriasis
Zai Lab Has Dosed The First Patient In The...
05/22/2024 11:34:45

This is the first compound in Zai's portfolio of internally developed drugs to advance into Phase 2, demonstrating Zai...

Core News & Articles
Zai Lab And Innoviva Specialty Therapeutic...
05/20/2024 04:40:14

Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, ...

reported-sunday-zai-lab-received-approval--of-augtyro-repotrectinib-for-patients-with-ros1-positive-nsclc-by-chinas-national-medical-products-administration
Reported Sunday, Zai Lab Received Approval...
05/13/2024 06:30:58

The approval is based on the pivotal TRIDENT-1 trial, in which AUGTYRO achieved a high response rate and durable responses, inc...

why-duolingo-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Duolingo Shares Are Trading Lower By A...
05/09/2024 17:57:05

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 16:31:09

spectrum-brands-posts-upbeat-results-joins-aersale-sinclair-icu-medical-and-other-big-stocks-moving-higher-on-thursday
Spectrum Brands Posts Upbeat Results, Join...
05/09/2024 14:25:23

top-5-health-care-stocks-that-could-sink-your-portfolio-in-q2
Top 5 Health Care Stocks That Could Sink Y...
05/09/2024 12:44:39

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION